ProShare Advisors LLC

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1357955 BETHESDA, MD

Position in MRVI

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$63,372

-$22,356 QoQ

Shares Held

22,393

-15.1% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ProShare Advisors LLC holds $466,757,935 across 164 Biotechnology names. MRVI ranks #144 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	373,532	$166,796,979
2	REGN	Regeneron Pharmaceuticals, Inc.	152,397	$117,748,018
3	ALNY	Alnylam Pharmaceuticals, Inc.	174,013	$57,575,681
4	INSM	INSMED Inc	283,141	$46,299,216
5	INCY	Incyte Corp	49,678	$4,675,693
6	MRNA	Moderna, Inc.	71,342	$3,624,173
7	BBIO	BridgeBio Pharma, Inc.	31,677	$2,352,334
8	ARWR	Arrowhead Pharmaceuticals, Inc.	31,498	$1,974,924

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$63,372	22,393	-15.1%	Shares	Sole	2026-04-27
2025-12-31	$85,728	26,378	+10.6%	Shares	Sole	2026-02-06
2025-09-30	$68,426	23,842	-21.6%	Shares	Sole	2025-11-06
2025-06-30	$73,278	30,406	-36.6%	Shares	Sole	2025-08-07
2025-03-31	$106,022	47,974	-13.5%	Shares	Sole	2025-05-08
2024-12-31	$302,409	55,488	+89.8%	Shares	Sole	2025-02-14
2024-09-30	$242,959	29,237	+133.2%	Shares	Sole	2024-11-14
2022-12-31	$179,418	12,538	-2.1%	Shares	Sole	2023-02-02
2022-09-30	$326,886	12,804	+6.5%	Shares	Sole	2022-11-07
2022-06-30	$341,459	12,019	-25.3%	Shares	Sole	2022-08-01
2022-03-31	$567,635	16,094	-24.3%	Shares	Sole	2022-05-10
2021-12-31	$890,500	21,253	—	Shares	Sole	2022-02-08
No filing history on record for this holder in this stock.